Document:

exv10w1

 

Exhibit 10.1

HANSEN MEDICAL, INC.

INDEMNITY AGREEMENT

     This Agreement is made and entered into this ___ day of                     , 2005 by and
between Hansen Medical, Inc., a Delaware corporation (the “Company”), and
                                         (the “Agent”).

Recitals

     Whereas, Agent performs a valuable service to the Company as a director of the
Company;

     Whereas, the stockholders of the Company have adopted bylaws (the “Bylaws”) providing
for the indemnification of the directors, officers, employees and other agents of the Company,
including persons serving at the request of the Company in such capacities with other corporations
or enterprises, as authorized by the Delaware General Corporation Law, as amended (the “Code”);

     Whereas, the Bylaws and the Code, by their non-exclusive nature, permit contracts
between the Company and its directors, officers, employees and other agents with respect to
indemnification of such persons; and

     Whereas, in order to induce Agent to continue to serve as a director of the Company,
the Company has determined and agreed to enter into this Agreement with Agent.

     Now, Therefore, in consideration of Agent’s continued service as a director after the
date hereof, the parties hereto agree as follows:

Agreement

     1. Services to the Company. Agent will serve, at the will of the Company or under separate
contract, if any such contract exists, as a director of the Company or as a director, officer or
other fiduciary of an affiliate of the Company (including any employee benefit plan of the Company)
faithfully and to the best of his or her ability so long as he or she is duly elected and qualified
in accordance with the provisions of the Bylaws or other applicable charter documents of the
Company or such affiliate; provided, however, that Agent may at any time and for any reason resign
from such position (subject to any contractual obligation that Agent may have assumed apart from
this Agreement) and that the Company or any affiliate shall have no obligation under this Agreement
to continue Agent in any such position.

     2. Indemnity of Agent. The Company hereby agrees to hold harmless and indemnify Agent to the
fullest extent authorized or permitted by the provisions of the Bylaws and the Code, as the same
may be amended from time to time. In the event of any change after

1.

 

the date of this Agreement in any applicable law, statute or rule that expands the right of a
Delaware corporation to indemnify a member of its Board of Directors or an officer, employee,
controlling person, agent or fiduciary, it is the intent of the parties hereto that the Agent shall
enjoy by this Agreement the greater benefits afforded by such change. In the event of any change
in any applicable law, statute or rule that narrows the right of a Delaware corporation to
indemnify a member of its Board of Directors or an officer, employee, agent or fiduciary, such
change, to the extent not otherwise required by such law, statute or rule to be applied to this
Agreement, shall have no effect on this Agreement or the parties’ rights and obligations hereunder.

     3. Additional Indemnity. In addition to and not in limitation of the indemnification
otherwise provided for herein, and subject only to the exclusions set forth in Section 5 hereof,
the Company hereby further agrees to hold harmless and indemnify Agent:

          (a) against any and all expenses (including attorneys’ fees), witness fees, damages,
judgments, fines and amounts paid in settlement and any other amounts that Agent becomes legally
obligated to pay because of any claim or claims made against or by him in connection with any
threatened, pending or completed action, suit or proceeding, whether civil, criminal,
arbitrational, administrative or investigative (including an action by or in the right of the
Company) to which Agent is, was or at any time becomes a party, or is threatened to be made a
party, by reason of the fact that Agent is, was or at any time becomes a director, officer,
employee or other agent of Company, or is or was serving or at any time serves at the request of
the Company as a director, officer, employee or other agent of another company, partnership, joint
venture, trust, employee benefit plan or other enterprise; and

          (b) otherwise to the fullest extent as may be provided to Agent by the Company under the
non-exclusivity provisions of the Code and Section 7.6 of the Bylaws.

     4. Indemnity of Related Parties. To the extent that Agent is serving on the Board of
Directors of the Company at the direction of any stockholder of the Company who, pursuant to the
Certificate of Incorporation or contractual arrangement, shall have the right to elect or appoint
Agent to the Board (an “Appointing Stockholder”), the Company shall indemnify and hold harmless
such Appointing Stockholder from any threatened, pending or completed action or proceeding, whether
civil, criminal, administrative or investigative, arising out of Appointing Stockholder’s ability
to appoint or elect Agent to the Board of Directors of the Company or any action taken or omitted
to be taken by Agent for which Agent is entitled to indemnification hereunder, provided however,
that (i) any such indemnification shall be subject to the same limitations set forth herein and
(ii) no such indemnification shall be available to any Appointing Stockholder in the event that
Agent shall not be entitled to indemnification in the same or any related action or proceeding. The
terms of this agreement as they relate to procedures for indemnification of Agent shall apply to
any such indemnification of Appointing Stockholder. Any Appointing Stockholder is an intended third
party beneficiary of this Agreement.

     5. Contribution. If the indemnification provided for in Sections 2, 3 and 4 above for any
reason is held by a court of competent jurisdiction to be unavailable to Agent in respect of any
losses, claims, damages, expenses or liabilities referred to therein, then the Company, in lieu of
indemnifying the Agent thereunder, shall contribute to the amount paid or payable by the

2.

 

Agent as a result of such losses, claims, damages, expenses or liabilities (i) in such
proportion as is appropriate to reflect the relative benefits received by the Company and the
Agent, or (ii) if the allocation provided by clause (i) above is not permitted by applicable law,
in such proportion as is appropriate to reflect not only the relative benefits referred to in
clause (i) above but also the relative fault of the Company and the Agent in connection with the
action or inaction that resulted in such losses, claims, damages, expenses or liabilities, as well
as any other relevant equitable considerations. In connection with the registration of the
Company’s securities, the relative benefits received by the Company and the Agent shall be deemed
to be in the same respective proportions that the net proceeds from the offering (before deducting
expenses) received by the Company and the Agent, in each case as set forth in the table on the
cover page of the applicable prospectus, bear to the aggregate public offering price of the
securities so offered. The relative fault of the Company and the Agent shall be determined by
reference to, among other things, whether the untrue or alleged untrue statement of a material fact
or the omission or alleged omission to state a material fact relates to information supplied by the
Company or the Agent and the parties’ relative intent, knowledge, access to information and
opportunity to correct or prevent such statement or omission.

     The Company and the Agent agree that it would not be just and equitable if contribution
pursuant to this Section 5 were determined by pro rata or per capita allocation or by any other
method of allocation that does not take account of the equitable considerations referred to in the
immediately preceding paragraph. In connection with the registration of the Company’s securities,
in no event shall Agent be required to contribute any amount under this Section 5 in excess of the
lesser of: (i) that proportion of the total of such losses, claims, damages or liabilities that
are indemnified against, equal to the proportion of the total securities sold under such
registration statement that is being sold by the Agent or (ii) the proceeds received by the Agent
from its sale of securities under such registration statement. No person found guilty of
fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act of 1933, as
amended) shall be entitled to contribution from any person who was not found guilty of such
fraudulent misrepresentation.

     6. Limitations on Additional Indemnity. No indemnity pursuant to Sections 3 or 4 hereof shall
be paid by the Company:

          (a) on account of any claim against Agent solely for an accounting of profits made from the
purchase or sale by Agent of securities of the Company pursuant to the provisions of Section 16(b)
of the Securities Exchange Act of 1934 and amendments thereto or similar provisions of any federal,
state or local statutory law;

          (b) on account of Agent’s conduct that is established by a final judgment as knowingly
fraudulent or deliberately dishonest or that constituted willful misconduct;

          (c) on account of Agent’s conduct that is established by a final judgment as constituting a
breach of Agent’s duty of loyalty to the Company or resulting in any personal profit or advantage
to which Agent was not legally entitled;

3.

 

          (d) for which payment is actually made to Agent under a valid and collectible insurance policy
or under a valid and enforceable indemnity clause, bylaw or agreement, except in respect of any
excess beyond payment under such insurance, clause, bylaw or agreement;

          (e) if indemnification is not lawful (and, in this respect, both the Company and Agent have
been advised that the Securities and Exchange Commission believes that indemnification for
liabilities arising under the federal securities laws is against public policy and is, therefore,
unenforceable and that claims for indemnification should be submitted to appropriate courts for
adjudication); or

          (f) in connection with any proceeding (or part thereof) initiated by Agent, or any proceeding
by Agent against the Company or its directors, officers, employees or other agents, unless (i) such
indemnification is expressly required to be made by law, (ii) the proceeding was authorized by the
Board of Directors of the Company, (iii) such indemnification is provided by the Company, in its
sole discretion, pursuant to the powers vested in the Company under the Code, or (iv) the
proceeding is initiated pursuant to Section 11 hereof.

     7. Continuation of Indemnity. All agreements and obligations of the Company contained herein
shall continue during the period Agent is a director, officer, employee or other agent of the
Company (or is or was serving at the request of the Company as a director, officer, employee or
other agent of another company, corporation, partnership, joint venture, trust, employee benefit
plan or other enterprise) and shall continue thereafter so long as Agent shall be subject to any
possible claim or threatened, pending or completed action, suit or proceeding, whether civil,
criminal, arbitrational, administrative or investigative, by reason of the fact that Agent was
serving in the capacity referred to herein.

     8. Partial Indemnification. Agent shall be entitled under this Agreement to indemnification
by the Company for a portion of the expenses (including attorneys’ fees), witness fees, damages,
judgments, fines and amounts paid in settlement and any other amounts that Agent becomes legally
obligated to pay in connection with any action, suit or proceeding referred to in Section 3 hereof
even if not entitled hereunder to indemnification for the total amount thereof, and the Company
shall indemnify Agent for the portion thereof to which Agent is entitled.

     9. Notification and Defense of Claim. Not later than thirty (30) days after receipt by Agent
of notice of the commencement of any action, suit or proceeding, Agent will, if a claim in respect
thereof is to be made against the Company under this Agreement, notify the Company of the
commencement thereof; but the omission so to notify the Company will not relieve it from any
liability which it may have to Agent except to the extent actually prejudiced by such omission.
With respect to any such action, suit or proceeding as to which Agent notifies the Company of the
commencement thereof:

          (a) the Company will be entitled to participate therein at its own expense;

          (b) except as otherwise provided below, the Company may, at its option and jointly with any
other indemnifying party similarly notified and electing to assume such defense, assume the defense
thereof, with counsel reasonably satisfactory to Agent. After notice from the

4.

 

Company to Agent of its election to assume the defense thereof, the Company will not be liable
to Agent under this Agreement for any legal or other expenses subsequently incurred by Agent in
connection with the defense thereof except for reasonable costs of investigation or otherwise as
provided below. Agent shall have the right to employ separate counsel in such action, suit or
proceeding but the fees and expenses of such counsel incurred after notice from the Company of its
assumption of the defense thereof shall be at the expense of Agent unless (i) the employment of
counsel by Agent has been authorized by the Company, (ii) Agent shall have reasonably concluded,
and so notified the Company, that there is an actual conflict of interest between the Company and
Agent in the conduct of the defense of such action or (iii) the Company shall not in fact have
employed counsel to assume the defense of such action, in each of which cases the fees and expenses
of Agent’s separate counsel shall be at the expense of the Company. The Company shall not be
entitled to assume the defense of any action, suit or proceeding brought by or on behalf of the
Company or as to which Agent shall have made the conclusion provided for in clause (ii) above; and

          (c) the Company shall not be liable to indemnify Agent under this Agreement for any amounts
paid in settlement of any action or claim effected without its written consent, which shall not be
unreasonably withheld, conditioned or delayed. The Company shall be permitted to settle any action
except that it shall not settle any action or claim in any manner which would impose any penalty or
limitation on Agent without Agent’s written consent, which may be given or withheld in Agent’s sole
discretion.

     10. Expenses. The Company shall advance, prior to the final disposition of any proceeding,
promptly following request therefor, all expenses incurred by Agent in connection with such
proceeding upon receipt of an undertaking by or on behalf of Agent to repay said amounts if it
shall be determined ultimately that Agent is not entitled to be indemnified under the provisions of
this Agreement, the Bylaws, the Code or otherwise. The Agent’s obligation to reimburse the Company
shall be unsecured and no interest shall be charged thereon.

     11. Enforcement. Any right to indemnification or advances granted by this Agreement to Agent
shall be enforceable by or on behalf of Agent in any court of competent jurisdiction if (i) the
claim for indemnification or advances is denied, in whole or in part, or (ii) no disposition of
such claim is made within ninety (90) days of request therefor. Agent, in such enforcement action,
if successful in whole or in part, shall be entitled to be paid also the expense of prosecuting his
claim. It shall be a defense to any action for which a claim for indemnification is made under
Section 3 hereof (other than an action brought to enforce a claim for expenses pursuant to Section
11 hereof, provided that the required undertaking has been tendered to the Company) that Agent is
not entitled to indemnification because of the limitations set forth in Section 6 hereof. Neither
the failure of the Company (including its Board of Directors or its stockholders) to have made a
determination prior to the commencement of such enforcement action that indemnification of Agent is
proper in the circumstances, nor an actual determination by the Company (including its Board of
Directors or its stockholders) that such indemnification is improper shall be a defense to the
action or create a presumption that Agent is not entitled to indemnification under this Agreement
or otherwise.

     12. Subrogation. In the event of payment under this Agreement, the Company shall be
subrogated to the extent of such payment to all of the rights of recovery of Agent, who shall

5.

 

execute all documents required and shall do all acts that may be necessary to secure such
rights and to enable the Company effectively to bring suit to enforce such rights; provided
however, any rights of recovery of Agent pursuant to any liability insurance policy separately paid
for by Agent or Agent’s affiliates or right to indemnity by any affiliate of Agent or any
stockholder of the Company shall not be subject to subrogation under this Section 12 except that
any amounts recovered under such policy shall be subject to Section 6(d).

     13. Non-Exclusivity of Rights. The rights conferred on Agent by this Agreement shall not be
exclusive of any other right which Agent may have or hereafter acquire under any statute, provision
of the Company’s Certificate of Incorporation or Bylaws, agreement, vote of stockholders or
directors, or otherwise, both as to action in his official capacity and as to action in another
capacity while holding office.

     14. Survival of Rights.

          (a) The rights conferred on Agent by this Agreement shall continue after Agent has ceased to
be a director, officer, employee or other agent of the Company or to serve at the request of the
Company as a director, officer, employee or other agent of another company, corporation,
partnership, joint venture, trust, employee benefit plan or other enterprise and shall inure to the
benefit of Agent’s heirs, executors and administrators.

          (b) The Company shall require any successor (whether direct or indirect, by purchase, merger,
consolidation or otherwise) to all or substantially all of the business or assets of the Company,
expressly to assume and agree to perform this Agreement in the same manner and to the same extent
that the Company would be required to perform if no such succession had taken place.

     15. Separability. Each of the provisions of this Agreement is a separate and distinct
agreement and independent of the others, so that if any provision hereof shall be held to be
invalid for any reason, such invalidity or unenforceability shall not affect the validity or
enforceability of the other provisions hereof. Furthermore, if this Agreement shall be invalidated
in its entirety on any ground, then the Company shall nevertheless indemnify Agent to the fullest
extent provided by the Bylaws, the Code or any other applicable law.

     16. Governing Law. This Agreement shall be interpreted and enforced in accordance with the
laws of the State of Delaware without regard to the conflicts of laws provisions thereof.

     17. Amendment and Termination. No amendment, modification, termination or cancellation of
this Agreement shall be effective unless in writing signed by both parties hereto.

     18. Identical Counterparts. This Agreement may be executed in one or more counterparts, each
of which shall for all purposes be deemed to be an original but all of which together shall
constitute but one and the same Agreement. Only one such counterpart need be produced to evidence
the existence of this Agreement.

6.

 

     19. Headings. The headings of the sections of this Agreement are inserted for convenience
only and shall not be deemed to constitute part of this Agreement or to affect the construction
hereof.

     20. Notices. All notices, requests, demands and other communications hereunder shall be in
writing and shall be deemed to have been duly given (i) upon delivery if delivered by hand to the
party to whom such communication was directed or (ii) upon the third business day after the date on
which such communication was mailed if mailed by certified or registered mail with postage prepaid:

          (a) If to Agent, at the address indicated on the signature page hereof.

          (b) If to the Company, to:

Hansen Medical, Inc.

380 North Bernardo Avenue

Mountain View, CA 94043

Attn: Larry Strauss

or to such other address as may have been furnished to Agent by the Company.

     21. Mandatory Payment of Expenses. Notwithstanding any other provision of this Agreement, to
the extent that Agent has been successful on the merits or otherwise, including, without
limitation, the dismissal of an action without prejudice, in the defense of any action, suit,
proceeding, inquiry or investigation referred to in Section 3 hereof or in the defense of any
claim, issue or matter therein, the Agent shall be indemnified against all expenses incurred by the
Agent in connection herewith.

     22. No Presumptions; Burden of Proof. For purposes of this Agreement, the termination of any
claim by judgment, order, settlement (whether with or without court approval) or conviction, or
upon a plea of nolo contendere, or its equivalent, shall not create a presumption that the Agent
did not meet any particular standard of conduct or have any particular belief or that a court has
determined that indemnification is not permitted by applicable law. In connection with any
determination as to whether the Agent is entitled to be indemnified hereunder, the burden of proof
shall be on the Company to establish that the Agent is not so entitled.

     23. Notice to Insurers. If, at the time of the receipt by the Company of a notice of a claim
pursuant to Section 9 hereof, the Company has liability insurance in effect that may cover such
claim, the Company shall give prompt notice of the commencement of such claim to the insurers in
accordance with the procedures set forth in each of the policies. The Company shall thereafter
take all necessary or desirable action to cause such insurers to pay, on behalf of the Agent, all
amounts payable as a result of such action, suit, proceeding, inquiry or investigation in
accordance with the terms of such policies.

     24. Liability Insurance. To the extent the Company maintains liability insurance applicable
to directors, officers, employees, control persons, agents or fiduciaries, the Agent

7.

 

shall be covered by such policies in such a manner as to provide the Agent the same rights and
benefits as are accorded to the most favorably insured of the Company’s directors, if the Agent is
a director, or of the Company’s officers, if the Agent is not a director of the Company but is an
officer; or of the Company’s key employees, controlling persons, agents or fiduciaries, if the
Agent is not an officer or director but is a key employee, agent, control person or fiduciary.

     25. Attorneys’ Fees. In the event that any action is instituted by Agent under this Agreement
or under any liability insurance policies maintained by the Company to enforce or interpret any of
the terms hereof or thereof, Agent shall be entitled to be paid all expenses incurred by Agent with
respect to such action, regardless of whether Agent is ultimately successful in such action, and
shall be entitled to the advancement of expenses with respect to such action, unless, as a part of
such action, a court of competent jurisdiction over such action determines that each of the
material assertions made by Agent as a basis for such action was not made in good faith or was
frivolous. In the event of an action instituted by or in the name of the Company under this
Agreement to enforce or interpret any of the terms of this Agreement, Agent shall be entitled to be
paid all expenses incurred by Agent in defense of such action (including costs and expenses
incurred with respect to Agent counterclaims and cross-claims made in such action), and shall be
entitled to the advancement of expenses with respect to such action, unless, as a part of such
action, a court having jurisdiction over such action determines that each of Agent’s material
defenses to such action was made in bad faith or was frivolous.

     26. Board and Stockholder Approval. The Company represents that this agreement has been
approved by the Company’s Board of Directors and stockholders.

[Signature Pages Follow]

8.

 

     In Witness Whereof, the parties hereto have executed this Agreement on and as of the
day and year first above written.

	 	 	 	 	 	 	 
	 	 	Hansen Medical, Inc.  
	 
	 	 	 	 	 	 
	 

	 	By:	 	 	 	 
	 

	 	 	 	 	 	 
	 
	 	 	 	 	 	 
	 

	 	Name:	 	 	 	 
	 

	 	 	 	 	 	 
	 
	 	 	 	 	 	 
	 

	 	Title:	 	 	 	 
	 

	 	 	 	 	 	 

	 	 	 	 	 	 	 
	 	 	AGENT
	 
	 	 	 	 	 	 
	 

	 	 	 	 	 	 
	 

	 	 	 	 	 	 
	 
	 	Name:	 	 	 	 
	 
	 	Address:	 	 	 	 

 

 

HANSEN MEDICAL, INC.

INDEMNITY AGREEMENT

     This
Agreement is made and entered into this ___ day of                     , 2006 by and
between Hansen Medical, Inc., a Delaware corporation (the “Company”), and
                                         (the “Agent”).

Recitals

     Whereas, Agent performs a valuable service to the Company as an executive officer of
the Company;

     Whereas, the stockholders of the Company have adopted bylaws (the “Bylaws”) providing
for the indemnification of the directors, officers, employees and other agents of the Company,
including persons serving at the request of the Company in such capacities with other corporations
or enterprises, as authorized by the Delaware General Corporation Law, as amended (the “Code”);

     Whereas, the Bylaws and the Code, by their non-exclusive nature, permit contracts
between the Company and its directors, officers, employees and other agents with respect to
indemnification of such persons; and

     Whereas, in order to induce Agent to continue to serve as an executive officer of the
Company, the Company has determined and agreed to enter into this Agreement with Agent.

     Now, Therefore, in consideration of Agent’s continued service as an executive officer
after the date hereof, the parties hereto agree as follows:

Agreement

     1. Services to the Company. Agent will serve, at the will of the Company or under separate
contract, if any such contract exists, as an executive officer of the Company or as a director,
officer or other fiduciary of an affiliate of the Company (including any employee benefit plan of
the Company) faithfully and to the best of his or her ability so long as he or she is duly elected
and qualified in accordance with the provisions of the Bylaws or other applicable charter documents
of the Company or such affiliate; provided, however, that Agent may at any time and for any reason
resign from such position (subject to any contractual obligation that Agent may have assumed apart
from this Agreement) and that the Company or any affiliate shall have no obligation under this
Agreement to continue Agent in any such position.

     2. Indemnity of Agent. The Company hereby agrees to hold harmless and indemnify Agent to the
fullest extent authorized or permitted by the provisions of the Bylaws and the Code, as the same
may be amended from time to time. In the event of any change after the date of this Agreement in
any applicable law, statute or rule that expands the right of a Delaware corporation to indemnify a
member of its Board of Directors or an officer, employee, controlling person, agent or fiduciary,
it is the intent of the parties hereto that the Agent shall enjoy by this Agreement the greater
benefits afforded by such change. In the event of any

1.

 

change in any applicable law, statute or rule that narrows the right of a Delaware corporation
to indemnify a member of its Board of Directors or an officer, employee, agent or fiduciary, such
change, to the extent not otherwise required by such law, statute or rule to be applied to this
Agreement, shall have no effect on this Agreement or the parties’ rights and obligations hereunder.

     3. Additional Indemnity. In addition to and not in limitation of the indemnification
otherwise provided for herein, and subject only to the exclusions set forth in Section 5 hereof,
the Company hereby further agrees to hold harmless and indemnify Agent:

          (a) against any and all expenses (including attorneys’ fees), witness fees, damages,
judgments, fines and amounts paid in settlement and any other amounts that Agent becomes legally
obligated to pay because of any claim or claims made against or by him in connection with any
threatened, pending or completed action, suit or proceeding, whether civil, criminal,
arbitrational, administrative or investigative (including an action by or in the right of the
Company) to which Agent is, was or at any time becomes a party, or is threatened to be made a
party, by reason of the fact that Agent is, was or at any time becomes a director, officer,
employee or other agent of Company, or is or was serving or at any time serves at the request of
the Company as a director, officer, employee or other agent of another company, partnership, joint
venture, trust, employee benefit plan or other enterprise; and

          (b) otherwise to the fullest extent as may be provided to Agent by the Company under the
non-exclusivity provisions of the Code and Section 7.6 of the Bylaws.

     4. Contribution. If the indemnification provided for in Sections 2 and 3 above for any
reason is held by a court of competent jurisdiction to be unavailable to Agent in respect of any
losses, claims, damages, expenses or liabilities referred to therein, then the Company, in lieu of
indemnifying the Agent thereunder, shall contribute to the amount paid or payable by the Agent as a
result of such losses, claims, damages, expenses or liabilities (i) in such proportion as is
appropriate to reflect the relative benefits received by the Company and the Agent, or (ii) if the
allocation provided by clause (i) above is not permitted by applicable law, in such proportion as
is appropriate to reflect not only the relative benefits referred to in clause (i) above but also
the relative fault of the Company and the Agent in connection with the action or inaction that
resulted in such losses, claims, damages, expenses or liabilities, as well as any other relevant
equitable considerations. In connection with the registration of the Company’s securities, the
relative benefits received by the Company and the Agent shall be deemed to be in the same
respective proportions that the net proceeds from the offering (before deducting expenses) received
by the Company and the Agent, in each case as set forth in the table on the cover page of the
applicable prospectus, bear to the aggregate public offering price of the securities so offered.
The relative fault of the Company and the Agent shall be determined by reference to, among other
things, whether the untrue or alleged untrue statement of a material fact or the omission or
alleged omission to state a material fact relates to information supplied by the Company or the
Agent and the parties’ relative intent, knowledge, access to information and opportunity to correct
or prevent such statement or omission.

          The Company and the Agent agree that it would not be just and equitable if contribution
pursuant to this Section 4 were determined by pro rata or per capita allocation or by

2.

 

any other method of allocation that does not take account of the equitable considerations referred
to in the immediately preceding paragraph. In connection with the registration of the Company’s
securities, in no event shall Agent be required to contribute any amount under this Section 5 in
excess of the lesser of: (i) that proportion of the total of such losses, claims, damages or
liabilities that are indemnified against, equal to the proportion of the total securities sold
under such registration statement that is being sold by the Agent or (ii) the proceeds received by
the Agent from its sale of securities under such registration statement. No person found guilty of
fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act of 1933, as
amended) shall be entitled to contribution from any person who was not found guilty of such
fraudulent misrepresentation.

     5. Limitations on Additional Indemnity. No indemnity pursuant to Section 3 hereof shall be
paid by the Company:

          (a) on account of any claim against Agent solely for an accounting of profits made from the
purchase or sale by Agent of securities of the Company pursuant to the provisions of Section 16(b)
of the Securities Exchange Act of 1934 and amendments thereto or similar provisions of any federal,
state or local statutory law;

          (b) on account of Agent’s conduct that is established by a final judgment as knowingly
fraudulent or deliberately dishonest or that constituted willful misconduct;

          (c) on account of Agent’s conduct that is established by a final judgment as constituting a
breach of Agent’s duty of loyalty to the Company or resulting in any personal profit or advantage
to which Agent was not legally entitled;

          (d) for which payment is actually made to Agent under a valid and collectible insurance policy
or under a valid and enforceable indemnity clause, bylaw or agreement, except in respect of any
excess beyond payment under such insurance, clause, bylaw or agreement;

          (e) if indemnification is not lawful (and, in this respect, both the Company and Agent have
been advised that the Securities and Exchange Commission believes that indemnification for
liabilities arising under the federal securities laws is against public policy and is, therefore,
unenforceable and that claims for indemnification should be submitted to appropriate courts for
adjudication); or

          (f) in connection with any proceeding (or part thereof) initiated by Agent, or any proceeding
by Agent against the Company or its directors, officers, employees or other agents, unless (i) such
indemnification is expressly required to be made by law, (ii) the proceeding was authorized by the
Board of Directors of the Company, (iii) such indemnification is provided by the Company, in its
sole discretion, pursuant to the powers vested in the Company under the Code, or (iv) the
proceeding is initiated pursuant to Section 11 hereof.

     6. Continuation of Indemnity. All agreements and obligations of the Company contained herein
shall continue during the period Agent is a director, officer, employee or other agent of the
Company (or is or was serving at the request of the Company as a director, officer, employee or
other agent of another company, corporation, partnership, joint venture, trust, employee benefit
plan or other enterprise) and shall continue thereafter so long as Agent shall be

3.

 

subject to any possible claim or threatened, pending or completed action, suit or proceeding,
whether civil, criminal, arbitrational, administrative or investigative, by reason of the fact that
Agent was serving in the capacity referred to herein.

     7. Partial Indemnification. Agent shall be entitled under this Agreement to indemnification
by the Company for a portion of the expenses (including attorneys’ fees), witness fees, damages,
judgments, fines and amounts paid in settlement and any other amounts that Agent becomes legally
obligated to pay in connection with any action, suit or proceeding referred to in Section 3 hereof
even if not entitled hereunder to indemnification for the total amount thereof, and the Company
shall indemnify Agent for the portion thereof to which Agent is entitled.

     8. Notification and Defense of Claim. Not later than thirty (30) days after receipt by Agent
of notice of the commencement of any action, suit or proceeding, Agent will, if a claim in respect
thereof is to be made against the Company under this Agreement, notify the Company of the
commencement thereof; but the omission so to notify the Company will not relieve it from any
liability which it may have to Agent except to the extent actually prejudiced by such omission.
With respect to any such action, suit or proceeding as to which Agent notifies the Company of the
commencement thereof:

          (a) the Company will be entitled to participate therein at its own expense;

          (b) except as otherwise provided below, the Company may, at its option and jointly with any
other indemnifying party similarly notified and electing to assume such defense, assume the defense
thereof, with counsel reasonably satisfactory to Agent. After notice from the Company to Agent of
its election to assume the defense thereof, the Company will not be liable to Agent under this
Agreement for any legal or other expenses subsequently incurred by Agent in connection with the
defense thereof except for reasonable costs of investigation or otherwise as provided below. Agent
shall have the right to employ separate counsel in such action, suit or proceeding but the fees and
expenses of such counsel incurred after notice from the Company of its assumption of the defense
thereof shall be at the expense of Agent unless (i) the employment of counsel by Agent has been
authorized by the Company, (ii) Agent shall have reasonably concluded, and so notified the Company,
that there is an actual conflict of interest between the Company and Agent in the conduct of the
defense of such action or (iii) the Company shall not in fact have employed counsel to assume the
defense of such action, in each of which cases the fees and expenses of Agent’s separate counsel
shall be at the expense of the Company. The Company shall not be entitled to assume the defense of
any action, suit or proceeding brought by or on behalf of the Company or as to which Agent shall
have made the conclusion provided for in clause (ii) above; and

          (c) the Company shall not be liable to indemnify Agent under this Agreement for any amounts
paid in settlement of any action or claim effected without its written consent, which shall not be
unreasonably withheld, conditioned or delayed. The Company shall be permitted to settle any action
except that it shall not settle any action or claim in any manner which would impose any penalty or
limitation on Agent without Agent’s written consent, which may be given or withheld in Agent’s sole
discretion.

4.

 

     9. Expenses. The Company shall advance, prior to the final disposition of any proceeding,
promptly following request therefor, all expenses incurred by Agent in connection with such
proceeding upon receipt of an undertaking by or on behalf of Agent to repay said amounts if it
shall be determined ultimately that Agent is not entitled to be indemnified under the provisions of
this Agreement, the Bylaws, the Code or otherwise. The Agent’s obligation to reimburse the Company
shall be unsecured and no interest shall be charged thereon.

     10. Enforcement. Any right to indemnification or advances granted by this Agreement to Agent
shall be enforceable by or on behalf of Agent in any court of competent jurisdiction if (i) the
claim for indemnification or advances is denied, in whole or in part, or (ii) no disposition of
such claim is made within ninety (90) days of request therefor. Agent, in such enforcement action,
if successful in whole or in part, shall be entitled to be paid also the expense of prosecuting his
claim. It shall be a defense to any action for which a claim for indemnification is made under
Section 3 hereof (other than an action brought to enforce a claim for expenses pursuant to Section
10 hereof, provided that the required undertaking has been tendered to the Company) that Agent is
not entitled to indemnification because of the limitations set forth in Section 5 hereof. Neither
the failure of the Company (including its Board of Directors or its stockholders) to have made a
determination prior to the commencement of such enforcement action that indemnification of Agent is
proper in the circumstances, nor an actual determination by the Company (including its Board of
Directors or its stockholders) that such indemnification is improper shall be a defense to the
action or create a presumption that Agent is not entitled to indemnification under this Agreement
or otherwise.

     11. Subrogation. In the event of payment under this Agreement, the Company shall be
subrogated to the extent of such payment to all of the rights of recovery of Agent, who shall
execute all documents required and shall do all acts that may be necessary to secure such rights
and to enable the Company effectively to bring suit to enforce such rights; provided however, any
rights of recovery of Agent pursuant to any liability insurance policy separately paid for by Agent
or Agent’s affiliates or right to indemnity by any affiliate of Agent or any stockholder of the
Company shall not be subject to subrogation under this Section 11 except that any amounts recovered
under such policy shall be subject to Section 5(d).

     12. Non-Exclusivity of Rights. The rights conferred on Agent by this Agreement shall not be
exclusive of any other right which Agent may have or hereafter acquire under any statute, provision
of the Company’s Certificate of Incorporation or Bylaws, agreement, vote of stockholders or
directors, or otherwise, both as to action in his official capacity and as to action in another
capacity while holding office.

     13. Survival of Rights.

          (a) The rights conferred on Agent by this Agreement shall continue after Agent has ceased to
be a director, officer, employee or other agent of the Company or to serve at the request of the
Company as a director, officer, employee or other agent of another company, corporation,
partnership, joint venture, trust, employee benefit plan or other enterprise and shall inure to the
benefit of Agent’s heirs, executors and administrators.

5.

 

          (b) The Company shall require any successor (whether direct or indirect, by purchase, merger,
consolidation or otherwise) to all or substantially all of the business or assets of the Company,
expressly to assume and agree to perform this Agreement in the same manner and to the same extent
that the Company would be required to perform if no such succession had taken place.

     14. Separability. Each of the provisions of this Agreement is a separate and distinct
agreement and independent of the others, so that if any provision hereof shall be held to be
invalid for any reason, such invalidity or unenforceability shall not affect the validity or
enforceability of the other provisions hereof. Furthermore, if this Agreement shall be invalidated
in its entirety on any ground, then the Company shall nevertheless indemnify Agent to the fullest
extent provided by the Bylaws, the Code or any other applicable law.

     15. Governing Law. This Agreement shall be interpreted and enforced in accordance with the
laws of the State of Delaware without regard to the conflicts of laws provisions thereof.

     16. Amendment and Termination. No amendment, modification, termination or cancellation of
this Agreement shall be effective unless in writing signed by both parties hereto.

     17. Identical Counterparts. This Agreement may be executed in one or more counterparts, each
of which shall for all purposes be deemed to be an original but all of which together shall
constitute but one and the same Agreement. Only one such counterpart need be produced to evidence
the existence of this Agreement.

     18. Headings. The headings of the sections of this Agreement are inserted for convenience
only and shall not be deemed to constitute part of this Agreement or to affect the construction
hereof.

     19. Notices. All notices, requests, demands and other communications hereunder shall be in
writing and shall be deemed to have been duly given (i) upon delivery if delivered by hand to the
party to whom such communication was directed or (ii) upon the third business day after the date on
which such communication was mailed if mailed by certified or registered mail with postage prepaid:

          (a) If to Agent, at the address indicated on the signature page hereof.

          (b) If to the Company, to:

Hansen Medical, Inc.

380 North Bernardo Avenue

Mountain View, CA 94043

Attn: Chief Financial Officer

or to such other address as may have been furnished to Agent by the Company.

     20. Mandatory Payment of Expenses. Notwithstanding any other provision of this Agreement, to
the extent that Agent has been successful on the merits or otherwise, including,

6.

 

without limitation, the dismissal of an action without prejudice, in the defense of any
action, suit, proceeding, inquiry or investigation referred to in Section 3 hereof or in the
defense of any claim, issue or matter therein, the Agent shall be indemnified against all expenses
incurred by the Agent in connection herewith.

     21. No Presumptions; Burden of Proof. For purposes of this Agreement, the termination of any
claim by judgment, order, settlement (whether with or without court approval) or conviction, or
upon a plea of nolo contendere, or its equivalent, shall not create a presumption that the Agent
did not meet any particular standard of conduct or have any particular belief or that a court has
determined that indemnification is not permitted by applicable law. In connection with any
determination as to whether the Agent is entitled to be indemnified hereunder, the burden of proof
shall be on the Company to establish that the Agent is not so entitled.

     22. Notice to Insurers. If, at the time of the receipt by the Company of a notice of a claim
pursuant to Section 8 hereof, the Company has liability insurance in effect that may cover such
claim, the Company shall give prompt notice of the commencement of such claim to the insurers in
accordance with the procedures set forth in each of the policies. The Company shall thereafter
take all necessary or desirable action to cause such insurers to pay, on behalf of the Agent, all
amounts payable as a result of such action, suit, proceeding, inquiry or investigation in
accordance with the terms of such policies.

     23. Liability Insurance. To the extent the Company maintains liability insurance applicable
to directors, officers, employees, control persons, agents or fiduciaries, the Agent shall be
covered by such policies in such a manner as to provide the Agent the same rights and benefits as
are accorded to the most favorably insured of the Company’s directors, if the Agent is a director,
or of the Company’s officers, if the Agent is not a director of the Company but is an officer; or
of the Company’s key employees, controlling persons, agents or fiduciaries, if the Agent is not an
officer or director but is a key employee, agent, control person or fiduciary.

     24. Attorneys’ Fees. In the event that any action is instituted by Agent under this Agreement
or under any liability insurance policies maintained by the Company to enforce or interpret any of
the terms hereof or thereof, Agent shall be entitled to be paid all expenses incurred by Agent with
respect to such action, regardless of whether Agent is ultimately successful in such action, and
shall be entitled to the advancement of expenses with respect to such action, unless, as a part of
such action, a court of competent jurisdiction over such action determines that each of the
material assertions made by Agent as a basis for such action was not made in good faith or was
frivolous. In the event of an action instituted by or in the name of the Company under this
Agreement to enforce or interpret any of the terms of this Agreement, Agent shall be entitled to be
paid all expenses incurred by Agent in defense of such action (including costs and expenses
incurred with respect to Agent counterclaims and cross-claims made in such action), and shall be
entitled to the advancement of expenses with respect to such action, unless, as a part of such
action, a court having jurisdiction over such action determines that each of Agent’s material
defenses to such action was made in bad faith or was frivolous.

     25. Board and Stockholder Approval. The Company represents that this agreement has been
approved by the Company’s Board of Directors and stockholders.

7.

 

     In Witness Whereof, the parties hereto have executed this Agreement on and as of the
day and year first above written.

	 	 	 	 	 	 	 
	 	 	Hansen Medical, Inc.  
	 
	 	 	 	 	 	 
	 

	 	By:	 	 	 	 
	 

	 	 	 	 	 	 
	 
	 	 	 	 	 	 
	 

	 	Name:	 	 	 	 
	 

	 	 	 	 	 	 
	 
	 	 	 	 	 	 
	 

	 	Title:	 	 	 	 
	 

	 	 	 	 	 	 
	 
	 	 	 	 	 	 
	 
	 	 	 	 	 	 
	 	 	Agent
	 
	 	 	 	 	 	 
	 	 	 	 	 
	 

	 	Name:	 	 	 	 
	 
	 	 	 	 	 	 
	 

	 	Address:exv10w2

 

Exhibit 10.2

Hansen Medical, Inc.

2002 Stock Plan

Adopted on March 6, 2003

 

 

TABLE OF CONTENTS

	 	 	 	 	 
	 	 	Page No.	 
	SECTION 1. ESTABLISHMENT AND PURPOSE
	 	 	1	 
	 
	 	 	 	 
	SECTION 2. ADMINISTRATION
	 	 	1	 
	 
	 	 	 	 
	(a) Committees of the Board of Directors
	 	 	1	 
	(b) Authority of the Board of Directors
	 	 	1	 
	 
	 	 	 	 
	SECTION 3. ELIGIBILITY
	 	 	1	 
	 
	 	 	 	 
	(a) General Rule
	 	 	1	 
	(b) Ten-Percent Stockholders
	 	 	1	 
	 
	 	 	 	 
	SECTION 4. STOCK SUBJECT TO PLAN
	 	 	2	 
	 
	 	 	 	 
	(a) Basic Limitation
	 	 	2	 
	(b) Additional Shares
	 	 	2	 
	 
	 	 	 	 
	SECTION 5. TERMS AND CONDITIONS OF AWARDS OR SALES
	 	 	2	 
	 
	 	 	 	 
	(a) Stock Purchase Agreement
	 	 	2	 
	(b) Duration of Offers and Nontransferability of Rights
	 	 	2	 
	(c) Purchase Price
	 	 	2	 
	(d) Withholding Taxes
	 	 	2	 
	(e) Restrictions on Transfer of Shares and Minimum Vesting
	 	 	3	 
	 
	 	 	 	 
	SECTION 6. TERMS AND CONDITIONS OF OPTIONS
	 	 	3	 
	 
	 	 	 	 
	(a) Stock Option Agreement
	 	 	3	 
	(b) Number of Shares
	 	 	3	 
	(c) Exercise Price
	 	 	3	 
	(d) Exercisability
	 	 	3	 
	(e) Accelerated Exercisability
	 	 	4	 
	(f) Basic Term
	 	 	4	 
	(g) Termination of Service (Except by Death)
	 	 	4	 
	(h) Leaves of Absence
	 	 	4	 
	(i) Death of Optionee
	 	 	5	 
	(j) Restrictions on Transfer of Shares and Minimum Vesting
	 	 	5	 
	(k) Transferability of Options
	 	 	5	 
	(l) Withholding Taxes
	 	 	6	 
	(m) No Rights as a Stockholder
	 	 	6	 
	(n) Modification, Extension and Assumption of Options
	 	 	6	 

i

 

	 	 	 	 	 
	 	 	Page No.	 
	SECTION 7. PAYMENT FOR SHARES
	 	 	6	 
	 
	 	 	 	 
	(a) General Rule
	 	 	6	 
	(b) Surrender of Stock
	 	 	6	 
	(c) Services Rendered
	 	 	6	 
	(d) Promissory Note
	 	 	6	 
	(e) Exercise/Sale
	 	 	7	 
	(f) Exercise/Pledge
	 	 	7	 
	 
	 	 	 	 
	SECTION 8. ADJUSTMENT OF SHARES
	 	 	7	 
	 
	 	 	 	 
	(a) General
	 	 	7	 
	(b) Mergers and Consolidations
	 	 	7	 
	(c) Reservation of Rights
	 	 	8	 
	 
	 	 	 	 
	SECTION 9. SECURITIES LAW REQUIREMENTS
	 	 	8	 
	 
	 	 	 	 
	(a) General
	 	 	8	 
	(b) Financial Reports
	 	 	8	 
	 
	 	 	 	 
	SECTION 10. NO RETENTION RIGHTS
	 	 	8	 
	 
	 	 	 	 
	SECTION 11. DURATION AND AMENDMENTS
	 	 	8	 
	 
	 	 	 	 
	(a) Term of the Plan
	 	 	8	 
	(b) Right to Amend or Terminate the Plan
	 	 	9	 
	(c) Effect of Amendment or Termination
	 	 	9	 
	 
	 	 	 	 
	SECTION 12. DEFINITIONS
	 	 	9	 

ii

 

Hansen Medical, Inc. 2002 Stock Plan

SECTION 1. ESTABLISHMENT AND PURPOSE.

     The purpose of the Plan is to offer selected persons an opportunity to acquire a proprietary
interest in the success of the Company, or to increase such interest, by purchasing Shares of the
Company’s Stock. The Plan provides both for the direct award or sale of Shares and for the grant
of Options to purchase Shares. Options granted under the Plan may include Nonstatutory Options as
well as ISOs intended to qualify under Section 422 of the Code.

     Capitalized terms are defined in Section 12.

SECTION 2. ADMINISTRATION.

     (a) Committees of the Board of Directors. The Plan may be administered by one or more
Committees. Each Committee shall consist of one or more members of the Board of Directors who have
been appointed by the Board of Directors. Each Committee shall have such authority and be
responsible for such functions as the Board of Directors has assigned to it. If no Committee has
been appointed, the entire Board of Directors shall administer the Plan. Any reference to the
Board of Directors in the Plan shall be construed as a reference to the Committee (if any) to whom
the Board of Directors has assigned a particular function.

     (b) Authority of the Board of Directors. Subject to the provisions of the Plan, the Board of
Directors shall have full authority and discretion to take any actions it deems necessary or
advisable for the administration of the Plan. All decisions, interpretations and other actions of
the Board of Directors shall be final and binding on all Purchasers, all Optionees and all persons
deriving their rights from a Purchaser or Optionee.

     SECTION 3. ELIGIBILITY.

     (a) General Rule. Only Employees, Outside Directors and Consultants shall be eligible for the
grant of Nonstatutory Options or the direct award or sale of Shares. Only Employees shall be
eligible for the grant of ISOs.

     (b) Ten-Percent Stockholders. A person who owns more than 10% of the total combined voting
power of all classes of outstanding stock of the Company, its Parent or any of its Subsidiaries
shall not be eligible for designation as an Optionee or Purchaser unless (i) the Exercise Price is
at least 110% of the Fair Market Value of a Share on the date of grant, (ii) the Purchase Price (if
any) is at least 100% of the Fair Market Value of a Share and (iii) in the case of an ISO, such ISO
by its terms is not exercisable after the expiration of five years from the date of grant. For
purposes of this Subsection (b), in determining stock ownership, the attribution rules of Section 424(d) of the
Code shall be applied.

 

 

SECTION 4. STOCK SUBJECT TO PLAN.

     (a) Basic Limitation. Not more than 10,316,036 Shares may be issued under the Plan (subject
to Subsection (b) below and Section 8). The number of Shares that are subject to Options or other
rights outstanding at any time under the Plan shall not exceed the number of Shares that then
remain available for issuance under the Plan. The Company, during the term of the Plan, shall at
all times reserve and keep available sufficient Shares to satisfy the requirements of the Plan.
Shares offered under the Plan may be authorized but unissued Shares or treasury Shares.

     (b) Additional Shares. In the event that Shares previously issued under the Plan are
reacquired by the Company pursuant to a forfeiture provision, right of repurchase or right of first
refusal, such Shares shall be added to the number of Shares then available for issuance under the
Plan. However, the aggregate number of Shares issued upon the exercise of ISOs (including Shares
reacquired by the Company) shall in no event exceed 200% of the number specified in Subsection (a)
above. In the event that an outstanding Option or other right for any reason expires or is
canceled, the Shares allocable to the unexercised portion of such Option or other right shall not
reduce the number of Shares available for issuance under the Plan.

SECTION 5. TERMS AND CONDITIONS OF AWARDS OR SALES.

     (a) Stock Purchase Agreement. Each award or sale of Shares under the Plan (other than upon
exercise of an Option) shall be evidenced by a Stock Purchase Agreement between the Purchaser and
the Company. Such award or sale shall be subject to all applicable terms and conditions of the
Plan and may be subject to any other terms and conditions which are not inconsistent with the Plan
and which the Board of Directors deems appropriate for inclusion in a Stock Purchase Agreement.
The provisions of the various Stock Purchase Agreements entered into under the Plan need not be
identical.

     (b) Duration of Offers and Nontransferability of Rights. Any right to acquire Shares under
the Plan (other than an Option) shall automatically expire if not exercised by the Purchaser within
30 days after the grant of such right was communicated to the Purchaser by the Company. Such right
shall not be transferable and shall be exercisable only by the Purchaser to whom such right was
granted.

     (c) Purchase Price. The Purchase Price of Shares to be offered under the Plan shall not be
less than 85% of the Fair Market Value of such Shares, and a higher percentage may be required by
Section 3(b). Subject to the
preceding sentence, the Board of Directors shall determine the Purchase Price at its sole
discretion. The Purchase Price shall be payable in a form described in Section 7.

     (d) Withholding Taxes. As a condition to the purchase of Shares, the Purchaser shall make
such arrangements as the Board of Directors may require for the satisfaction of any federal, state,
local or foreign withholding tax obligations that may arise in connection with such purchase.

2

 

     (e) Restrictions on Transfer of Shares and Minimum Vesting. Any Shares awarded or sold under
the Plan shall be subject to such special forfeiture conditions, rights of repurchase, rights of
first refusal and other transfer restrictions as the Board of Directors may determine. Such
restrictions shall be set forth in the applicable Stock Purchase Agreement and shall apply in
addition to any restrictions that may apply to holders of Shares generally. In the case of a
Purchaser who is not an officer of the Company, an Outside Director or a Consultant:

     (i) Any right to repurchase the Purchaser’s Shares at the original Purchase
Price (if any) upon termination of the Purchaser’s Service shall lapse at least as
rapidly as 20% per year over the five-year period commencing on the date of the
award or sale of the Shares;

     (ii) Any such right may be exercised only for cash or for cancellation of
indebtedness incurred in purchasing the Shares; and

     (iii) Any such right may be exercised only within 90 days after the termination
of the Purchaser’s Service.

SECTION 6. TERMS AND CONDITIONS OF OPTIONS.

     (a) Stock Option Agreement. Each grant of an Option under the Plan shall be evidenced by a
Stock Option Agreement between the Optionee and the Company. The Option shall be subject to all
applicable terms and conditions of the Plan and may be subject to any other terms and conditions
which are not inconsistent with the Plan and which the Board of Directors deems appropriate for
inclusion in a Stock Option Agreement. The provisions of the various Stock Option Agreements
entered into under the Plan need not be identical.

     (b) Number of Shares. Each Stock Option Agreement shall specify the number of Shares that are
subject to the Option and shall provide for the adjustment of such number in accordance with
Section 8. The Stock Option Agreement shall also specify whether the Option is an ISO or a
Nonstatutory Option.

     (c) Exercise Price. Each Stock Option Agreement shall specify the Exercise Price. The
Exercise Price of an ISO shall not be less than 100% of the Fair Market Value of a Share on the
date of grant, and a higher percentage may be required by Section 3(b). The Exercise Price of a
Nonstatutory Option shall not be less than 85%
of the Fair Market Value of a Share on the date of grant, and a higher percentage may be
required by Section 3(b). Subject to the preceding two sentences, the Exercise Price under any
Option shall be determined by the Board of Directors at its sole discretion. The Exercise Price
shall be payable in a form described in Section 7.

     (d) Exercisability. Each Stock Option Agreement shall specify the date when all or any
installment of the Option is to become exercisable. No Option shall be exercisable unless the
Optionee has delivered an executed copy of the Stock Option Agreement to the Company. In the case
of an Optionee who is not an officer of the Company, an Outside Director or a Consultant, an Option
shall become exercisable at least as rapidly as 20% per year over the five-year period commencing
on the date of grant. Subject to the preceding sentence, the Board

3

 

of Directors shall determine
the exercisability provisions of the Stock Option Agreement at its sole discretion.

     (e) Accelerated Exercisability. Unless the applicable Stock Option Agreement provides
otherwise, all of an Optionee’s Options shall become exercisable in full if (i) the Company is
subject to a Change in Control before the Optionee’s Service terminates, (ii) such Options do not
remain outstanding, (iii) such Options are not assumed by the surviving corporation or its parent
and (iv) the surviving corporation or its parent does not substitute options with substantially the
same terms for such Options.

     (f) Basic Term. The Stock Option Agreement shall specify the term of the Option. The term
shall not exceed 10 years from the date of grant, and a shorter term may be required by Section
3(b). Subject to the preceding sentence, the Board of Directors at its sole discretion shall
determine when an Option is to expire.

     (g) Termination of Service (Except by Death). If an Optionee’s Service terminates for any
reason other than the Optionee’s death, then the Optionee’s Options shall expire on the earliest of
the following occasions:

     (i) The expiration date determined pursuant to Subsection (f) above;

     (ii) The date three months after the termination of the Optionee’s Service for
any reason other than Disability, or such later date as the Board of Directors may
determine; or

     (iii) The date six months after the termination of the Optionee’s Service by
reason of Disability, or such later date as the Board of Directors may determine.

The Optionee may exercise all or part of the Optionee’s Options at any time before the expiration
of such Options under the preceding sentence, but only to the extent that such Options had become
exercisable before the Optionee’s Service terminated (or became exercisable as a result of the
termination) and the underlying Shares had vested before the Optionee’s Service
terminated (or vested as a result of the termination). The balance of such Options shall lapse
when the Optionee’s Service terminates. In the event that the Optionee dies after the termination
of the Optionee’s Service but before the expiration of the Optionee’s Options, all or part of such
Options may be exercised (prior to expiration) by the executors or administrators of the Optionee’s
estate or by any person who has acquired such Options directly from the Optionee by beneficiary
designation, bequest or inheritance, but only to the extent that such Options had become
exercisable before the Optionee’s Service terminated (or became exercisable as a result of the
termination) and the underlying Shares had vested before the Optionee’s Service terminated (or
vested as a result of the termination).

     (h) Leaves of Absence. For purposes of Subsection (g) above, Service shall be deemed to
continue while the Optionee is on a bona fide leave of absence, if such leave was approved by the
Company in writing and if continued crediting of Service for this purpose is

4

 

expressly required by
the terms of such leave or by applicable law (as determined by the Company).

     (i) Death of Optionee. If an Optionee dies while the Optionee is in Service, then the
Optionee’s Options shall expire on the earlier of the following dates:

     (i) The expiration date determined pursuant to Subsection (f) above; or

     (ii) The date 12 months after the Optionee’s death, or such later date as the
Board of Directors may determine.

All or part of the Optionee’s Options may be exercised at any time before the expiration of such
Options under the preceding sentence by the executors or administrators of the Optionee’s estate or
by any person who has acquired such Options directly from the Optionee by beneficiary designation,
bequest or inheritance, but only to the extent that such Options had become exercisable before the
Optionee’s death (or became exercisable as a result of the death) and the underlying Shares had
vested before the Optionee’s death (or vested as a result of the Optionee’s death). The balance of
such Options shall lapse when the Optionee dies.

     (j) Restrictions on Transfer of Shares and Minimum Vesting. Any Shares issued upon exercise
of an Option shall be subject to such special forfeiture conditions, rights of repurchase, rights
of first refusal and other transfer restrictions as the Board of Directors may determine. Such
restrictions shall be set forth in the applicable Stock Option Agreement and shall apply in
addition to any restrictions that may apply to holders of Shares generally. In the case of an
Optionee who is not an officer of the Company, an Outside Director or a Consultant:

     (i) Any right to repurchase the Optionee’s Shares at the original Exercise
Price upon termination of the Optionee’s Service shall lapse at least as rapidly as
20% per year over the five-year period commencing on the date of the option grant;

     (ii) Any such right may be exercised only for cash or for cancellation of
indebtedness incurred in purchasing the Shares; and

     (iii) Any such right may be exercised only within 90 days after the later of
(A) the termination of the Optionee’s Service or (B) the date of the option
exercise.

     (k) Transferability of Options. An Option shall be transferable by the Optionee only by (i) a
beneficiary designation, (ii) a will or (iii) the laws of descent and distribution, except as
provided in the next sentence. If the applicable Stock Option Agreement so provides, an NSO shall
also be transferable by the Optionee by (i) a gift to a member of the Optionee’s Immediate Family
or (ii) a gift to an inter vivos or testamentary trust in which members of the Optionee’s Immediate
Family have a beneficial interest of more than 50% and which provides that such NSO is to be
transferred to the beneficiaries upon the Optionee’s death. An ISO may be exercised during the
lifetime of the Optionee only by the Optionee or by the Optionee’s guardian or legal
representative.

5

 

     (l) Withholding Taxes. As a condition to the exercise of an Option, the Optionee shall make
such arrangements as the Board of Directors may require for the satisfaction of any federal, state,
local or foreign withholding tax obligations that may arise in connection with such exercise. The
Optionee shall also make such arrangements as the Board of Directors may require for the
satisfaction of any federal, state, local or foreign withholding tax obligations that may arise in
connection with the disposition of Shares acquired by exercising an Option.

     (m) No Rights as a Stockholder. An Optionee, or a transferee of an Optionee, shall have no
rights as a stockholder with respect to any Shares covered by the Optionee’s Option until such
person becomes entitled to receive such Shares by filing a notice of exercise and paying the
Exercise Price pursuant to the terms of such Option.

     (n) Modification, Extension and Assumption of Options. Within the limitations of the Plan,
the Board of Directors may modify, extend or assume outstanding Options or may accept the
cancellation of outstanding Options (whether granted by the Company or another issuer) in return
for the grant of new Options for the same or a different number of Shares and at the same or a
different Exercise Price. The foregoing notwithstanding, no modification of an Option shall,
without the consent of the Optionee, impair the Optionee’s rights or increase the Optionee’s
obligations under such Option.

SECTION 7. PAYMENT FOR SHARES.

     (a) General Rule. The entire Purchase Price or Exercise Price of Shares issued under the Plan
shall be payable in cash or cash equivalents at the time when such Shares are purchased, except as
otherwise provided in this Section 7.

     (b) Surrender of Stock. To the extent that a Stock Option Agreement so provides, all or any
part of the Exercise Price may be paid by surrendering, or attesting to the ownership of, Shares
that are already owned by the Optionee. Such Shares shall be surrendered to the Company in good
form for transfer and shall be valued at their Fair Market Value on the date when the Option is
exercised. The Optionee shall not surrender, or attest to the ownership of, Shares in payment of
the Exercise Price if such action would cause the Company to recognize compensation expense (or
additional compensation expense) with respect to the Option for financial reporting purposes.

     (c) Services Rendered. At the discretion of the Board of Directors, Shares may be awarded
under the Plan in consideration of services rendered to the Company, a Parent or a Subsidiary prior
to the award.

     (d) Promissory Note. To the extent that a Stock Option Agreement or Stock Purchase Agreement
so provides, all or a portion of the Exercise Price or Purchase Price (as the case may be) of
Shares issued under the Plan may be paid with a full-recourse promissory note. However, the par
value of the Shares, if newly issued, shall be paid in cash or cash equivalents. The Shares shall
be pledged as security for payment of the principal amount of the promissory note and interest
thereon. The interest rate payable under the terms of the promissory note shall not be less than
the minimum rate (if any) required to avoid the imputation of additional interest under the Code.
Subject to the foregoing, the Board of Directors (at its sole discretion) shall

6

 

specify the term,
interest rate, amortization requirements (if any) and other provisions of such note.

     (e) Exercise/Sale. To the extent that a Stock Option Agreement so provides, and if Stock is
publicly traded, payment may be made all or in part by the delivery (on a form prescribed by the
Company) of an irrevocable direction to a securities broker approved by the Company to sell Shares
and to deliver all or part of the sales proceeds to the Company in payment of all or part of the
Exercise Price and any withholding taxes.

     (f) Exercise/Pledge. To the extent that a Stock Option Agreement so provides, and if Stock is
publicly traded, payment may be made all or in part by the delivery (on a form prescribed by the
Company) of an irrevocable direction to pledge Shares to a securities broker or lender approved by
the Company, as security for a loan, and to deliver all or part of the loan proceeds to the Company
in payment of all or part of the Exercise Price and any withholding taxes.

SECTION 8. ADJUSTMENT OF SHARES.

     (a) General. In the event of a subdivision of the outstanding Stock, a declaration of a
dividend payable in Shares or a combination or consolidation of the outstanding Stock into a lesser
number of Shares, corresponding adjustments shall automatically be made in each of (i) the number
of Shares available for future grants under Section 4, (ii) the number of Shares covered by each
outstanding Option and (iii) the Exercise Price under each outstanding Option. In the event of a
declaration of an extraordinary dividend
payable in a form other than Shares in an amount that has a material effect on the Fair Market
Value of the Stock, a recapitalization, a spin-off, a reclassification or a similar occurrence, the
Board of Directors at its sole discretion may make appropriate adjustments in one or more of (i)
the number of Shares available for future grants under Section 4, (ii) the number of Shares covered
by each outstanding Option or (iii) the Exercise Price under each outstanding Option.

     (b) Mergers and Consolidations. In the event that the Company is a party to a merger or
consolidation, outstanding Options shall be subject to the agreement of merger or consolidation.
Such agreement shall provide for:

     (i) The continuation of such outstanding Options by the Company (if the Company
is the surviving corporation);

     (ii) The assumption of the Plan and such outstanding Options by the surviving
corporation or its parent;

     (iii) The substitution by the surviving corporation or its parent of options
with substantially the same terms for such outstanding Options;

     (iv) The full exercisability of such outstanding Options and full vesting of
the Shares subject to such Options, followed by the cancellation of such Options; or

7

 

     (v) The settlement of the full value of such outstanding Options (whether or
not then exercisable) in cash or cash equivalents, followed by the cancellation of
such Options.

     (c) Reservation of Rights. Except as provided in this Section 8, an Optionee or Purchaser
shall have no rights by reason of (i) any subdivision or consolidation of shares of stock of any
class, (ii) the payment of any dividend or (iii) any other increase or decrease in the number of
shares of stock of any class. Any issuance by the Company of shares of stock of any class, or
securities convertible into shares of stock of any class, shall not affect, and no adjustment by
reason thereof shall be made with respect to, the number or Exercise Price of Shares subject to an
Option. The grant of an Option pursuant to the Plan shall not affect in any way the right or power
of the Company to make adjustments, reclassifications, reorganizations or changes of its capital or
business structure, to merge or consolidate or to dissolve, liquidate, sell or transfer all or any
part of its business or assets.

SECTION 9. SECURITIES LAW REQUIREMENTS.

     (a) General. Shares shall not be issued under the Plan unless the issuance and delivery of
such Shares comply with (or are exempt from) all applicable requirements of law, including (without
limitation) the Securities Act of 1933, as amended, the rules and regulations promulgated
thereunder, state securities laws and regulations,
and the regulations of any stock exchange or other securities market on which the Company’s
securities may then be traded.

     (b) Financial Reports. The Company each year shall furnish to Optionees, Purchasers and
stockholders who have received Stock under the Plan its balance sheet and income statement, unless
such Optionees, Purchasers or stockholders are key Employees whose duties with the Company assure
them access to equivalent information. Such balance sheet and income statement need not be
audited.

SECTION 10. NO RETENTION RIGHTS.

     Nothing in the Plan or in any right or Option granted under the Plan shall confer upon the
Purchaser or Optionee any right to continue in Service for any period of specific duration or
interfere with or otherwise restrict in any way the rights of the Company (or any Parent or
Subsidiary employing or retaining the Purchaser or Optionee) or of the Purchaser or Optionee, which
rights are hereby expressly reserved by each, to terminate his or her Service at any time and for
any reason, with or without cause.

SECTION 11. DURATION AND AMENDMENTS.

     (a) Term of the Plan. The Plan, as set forth herein, shall become effective on the date of
its adoption by the Board of Directors, subject to the approval of the Company’s stockholders. If
the stockholders fail to approve the Plan within 12 months after its adoption by the Board of
Directors, then any grants, exercises or sales that have already occurred under the Plan shall be
rescinded and no additional grants, exercises or sales shall thereafter be made under

8

 

the Plan.
The Plan shall terminate automatically 10 years after the later of (i) its adoption by the Board of
Directors or (ii) the most recent increase in the number of Shares reserved under Section 4 that
was approved by the Company’s stockholders. The Plan may be terminated on any earlier date
pursuant to Subsection (b) below.

     (b) Right to Amend or Terminate the Plan. The Board of Directors may amend, suspend or
terminate the Plan at any time and for any reason; provided, however, that any amendment of the
Plan shall be subject to the approval of the Company’s stockholders if it (i) increases the number
of Shares available for issuance under the Plan (except as provided in Section 8) or (ii)
materially changes the class of persons who are eligible for the grant of ISOs. Stockholder
approval shall not be required for any other amendment of the Plan. If the stockholders fail to
approve an increase in the number of Shares reserved under Section 4 within 12 months after its
adoption by the Board of Directors, then any grants, exercises or sales that have already occurred
in reliance on such increase shall be rescinded and no additional grants, exercises or sales shall
thereafter be made in reliance on such increase.

     (c) Effect of Amendment or Termination. No Shares shall be issued or sold under the Plan
after the termination thereof, except upon exercise of an Option granted prior to such termination.
The termination of the Plan, or any amendment thereof, shall not affect any Share previously
issued or any Option previously granted under the Plan.

SECTION 12. DEFINITIONS.

     (a) “Board of Directors” shall mean the Board of Directors of the Company, as constituted from
time to time.

     (b) “Change in Control” shall mean (i) the consummation of a merger or consolidation of the
Company with or into another entity or (ii) the dissolution, liquidation or winding up of the
Company. The foregoing notwithstanding, a merger or consolidation of the Company shall not
constitute a “Change in Control” if immediately after such merger or consolidation a majority of
the voting power of the capital stock of the continuing or surviving entity, or any direct or
indirect parent corporation of such continuing or surviving entity, will be owned by the persons
who were the Company’s stockholders immediately prior to such merger or consolidation in
substantially the same proportions as their ownership of the voting power of the Company’s capital
stock immediately prior to such merger or consolidation.

     (c) “Code” shall mean the Internal Revenue Code of 1986, as amended.

     (d) “Committee” shall mean a committee of the Board of Directors, as described in Section
2(a).

     (e) “Company” shall mean Hansen Medical, Inc., a Delaware corporation.

     (f) “Consultant” shall mean a person who performs bona fide services for the Company, a Parent
or a Subsidiary as a consultant or advisor, excluding Employees and Outside Directors.

9

 

     (g) “Disability” shall mean that the Optionee is unable to engage in any substantial gainful
activity by reason of any medically determinable physical or mental impairment.

     (h) “Employee” shall mean any individual who is a common-law employee of the Company, a Parent
or a Subsidiary.

     (i) “Exercise Price” shall mean the amount for which one Share may be purchased upon exercise
of an Option, as specified by the Board of Directors in the applicable Stock Option Agreement.

     (j) “Fair Market Value” shall mean the fair market value of a Share, as determined by the
Board of Directors in good faith. Such determination shall be conclusive and binding on all
persons.

     (k) “Immediate Family” shall mean any child, stepchild, grandchild, parent, stepparent,
grandparent, spouse, sibling, mother-in-law, father-in-law, son-in-law, daughter-in-law,
brother-in-law or sister-in-law and shall include adoptive relationships.

     (l) “ISO” shall mean an employee incentive stock option described in Section 422(b) of the
Code.

     (m) “Nonstatutory Option” shall mean a stock option not described in Sections 422(b) or 423(b)
of the Code.

     (n) “Option” shall mean an ISO or Nonstatutory Option granted under the Plan and entitling the
holder to purchase Shares.

     (o) “Optionee” shall mean a person who holds an Option.

     (p) “Outside Director” shall mean a member of the Board of Directors who is not an Employee.

     (q) “Parent” shall mean any corporation (other than the Company) in an unbroken chain of
corporations ending with the Company, if each of the corporations other than the Company owns stock
possessing 50% or more of the total combined voting power of all classes of stock in one of the
other corporations in such chain. A corporation that attains the status of a Parent on a date
after the adoption of the Plan shall be considered a Parent commencing as of such date.

     (r) “Plan” shall mean this Hansen Medical, Inc. 2002 Stock Plan.

     (s) “Purchase Price” shall mean the consideration for which one Share may be acquired under
the Plan (other than upon exercise of an Option), as specified by the Board of Directors.

     (t) “Purchaser” shall mean a person to whom the Board of Directors has offered the right to
acquire Shares under the Plan (other than upon exercise of an Option).

10

 

     (u) “Service” shall mean service as an Employee, Outside Director or Consultant.

     (v) “Share” shall mean one share of Stock, as adjusted in accordance with Section 8 (if
applicable).

     (w) “Stock” shall mean the Common Stock of the Company, with a par value of $0.0001 per Share.

     (x) “Stock Option Agreement” shall mean the agreement between the Company and an Optionee that
contains the terms, conditions and restrictions pertaining to the Optionee’s Option.

     (y) “Stock Purchase Agreement” shall mean the agreement between the Company and a Purchaser
who acquires Shares under the Plan that contains the terms, conditions and restrictions pertaining
to the acquisition of such Shares.

     (z) “Subsidiary” shall mean any corporation (other than the Company) in an unbroken chain of
corporations beginning with the Company, if each of the corporations other than the last
corporation in the unbroken chain owns stock possessing 50% or more of the total combined voting
power of all classes of stock in one of the other corporations in such chain. A corporation that
attains the status of a Subsidiary on a date after the adoption of the Plan shall be considered a
Subsidiary commencing as of such date.

11

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00108-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00108-of-00352.parquet"}]]